TY - JOUR
T1 - The HOLA COVID-19 Study
T2 - An International Effort to Determine How COVID-19 Has Impacted Oncology Practices in Latin America
AU - Bernabe-Ramirez, Carolina
AU - Velazquez, Ana I.
AU - Olazagasti, Coral
AU - Bergerot, Cristiane Decat
AU - Bergerot, Paulo Gustavo
AU - Soto-Perez-de-Celis, Enrique
AU - Duma, Narjust
N1 - Funding Information:
The authors would like to thank all the HOLA COVID-19 study ambassadors and collaborators. An immediate family member of A.I.V. is a former employee of Johnson & Johnson Innovation; A.I.V. also reports stock ownership in Portola Pharmaceuticals, Corbus Pharmaceuticals, and Midatech. N.D. declares consultant/advisory roles with AstraZeneca, Pfizer, and Inivata, Inc.
Publisher Copyright:
© 2020
PY - 2020/11/9
Y1 - 2020/11/9
N2 - Countries in Latin America and the Caribbean have become hotspots of the novel coronavirus (COVID-19) pandemic, exacerbating socioeconomic inequalities and overwhelming fragmented health systems. Studies from the United States and Europe have highlighted the disproportionate effects of COVID-19 on patients with cancer and the disruption it has caused on cancer care delivery. The HOLA COVID-19 Study aims to understand how cancer care in Latin American countries has been affected by the COVID-19 pandemic.
AB - Countries in Latin America and the Caribbean have become hotspots of the novel coronavirus (COVID-19) pandemic, exacerbating socioeconomic inequalities and overwhelming fragmented health systems. Studies from the United States and Europe have highlighted the disproportionate effects of COVID-19 on patients with cancer and the disruption it has caused on cancer care delivery. The HOLA COVID-19 Study aims to understand how cancer care in Latin American countries has been affected by the COVID-19 pandemic.
UR - http://www.scopus.com/inward/record.url?scp=85093914864&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85093914864&partnerID=8YFLogxK
U2 - 10.1016/j.ccell.2020.10.013
DO - 10.1016/j.ccell.2020.10.013
M3 - Comment/debate
C2 - 33098754
AN - SCOPUS:85093914864
SN - 1535-6108
VL - 38
SP - 605
EP - 608
JO - Cancer Cell
JF - Cancer Cell
IS - 5
ER -